APOA5 rs964188: What Your Genotype Means
The genetic variant rs964188 is a single nucleotide polymorphism located in the 3' untranslated or intergenic region near the APOA5 gene cluster on chromosome 11. Large-scale genome-wide association studies link this marker to variations in circulating serum triglyceride concentrations and broad lipid profiles. While carrying the minor allele is associated with elevated triglycerides, it is only one contributing factor among complex polygenic and lifestyle influences.
What each genotype means
Typical triglyceride metabolism
This genotype represents the most common version of this genetic region. Research suggests individuals with this profile typically maintain baseline levels of triglyceride metabolism compared to those carrying the minor allele.
Carried by the majority of individuals in most global populations, though frequencies vary by ancestry.
Potential for elevated triglycerides
Carrying one copy of the minor allele is associated with a statistical tendency toward higher serum triglyceride levels in some studies. Because this variant is part of a complex gene cluster, your actual lipid levels are influenced by a combination of genetics, diet, and lifestyle factors.
The minor allele (T) is found in approximately 10-15% of European populations, making this heterozygous genotype relatively common.
Increased triglyceride risk profile
Individuals with two copies of the minor allele have been observed in research to have a higher statistical association with elevated serum triglyceride levels. This variant is linked to the regulation of lipid metabolism, and you should discuss your lipid panel results and cardiovascular risk factors with your healthcare provider.
This homozygous genotype is less common, occurring in a smaller percentage of the population depending on ancestral background.
Genomic Location and Variant Characteristics
The single nucleotide polymorphism rs964188 sits on chromosome 11 within the well-characterized APOA1/C3/A4/A5 gene cluster. This region contains multiple genes responsible for encoding apolipoproteins, which are critical protein components of lipoprotein particles. The variant rs964188 itself is a non-coding polymorphism, primarily representing a common single base substitution between guanine (G) and cytosine (C), though some platform strands report it as a thymine (T) transition depending on orientation. Because it resides in a non-coding regulatory domain adjacent to the APOA5 locus, it does not alter protein sequences directly. Instead, researchers hypothesize that rs964188 modulates transcriptional activity, alters messenger RNA stability, or serves as a genomic proxy in high linkage disequilibrium with other causal variants in the apolipoprotein cluster.
Biological Role of APOA5 and Lipid Regulation
The APOA5 gene encodes apolipoprotein A-V (apoA-V), an essential regulatory molecule in human lipoprotein metabolism. Despite circulating at comparatively low concentrations compared to other apolipoproteins like apoA-I or apoB, apoA-V exerts an outsized effect on triglyceride homeostasis. Mechanistic research indicates that apoA-V facilitates the catabolism of triglyceride-rich lipoproteins, including very low-density lipoproteins (VLDL) and chylomicrons, by stimulating lipoprotein lipase (LPL) activity and attenuating ANGPTL3/8-mediated LPL inhibition. Furthermore, apoA-V plays a role in dampening hepatic VLDL particle production. Consequently, structural alterations or regulatory shifts in APOA5 expression can impair the clearance of circulating fats from the bloodstream, setting the stage for elevated circulating triglycerides.
Research Associations and Strength of Evidence
Dozens of genome-wide association studies (GWAS) indexed in public catalogs have consistently identified rs964188 as one of the strongest common genetic signals associated with elevated serum triglycerides and altered high-density lipoprotein cholesterol (HDL-C). Evidence across multinational cohorts has documented that carriers of the minor C allele display statistically higher mean triglyceride concentrations compared to non-carriers. Secondary associations have been observed with features of metabolic syndrome, including lower HDL-C, altered postprandial lipemia, and increased risk profiles for coronary artery disease. However, evidence remains statistical and trait-focused rather than diagnostic. The effect size of any individual copy of this common variant is modest, explaining only a small percentage of variance in overall lipid levels, with outcomes heavily modified by environmental exposures such as diet, exercise, and body composition.
Population Distribution and Frequency Patterns
The minor allele (C) at rs964188 exhibits varying frequencies across global populations recorded in reference datasets such as gnomAD and 1000 Genomes. In populations of European ancestry, the minor allele frequency typically ranges between 10% and 15%. Considerably higher allele frequencies—often exceeding 20% to 30%—have been documented in certain East Asian and South Asian populations, where research groups have also reported robust associations with triglyceride traits. Conversely, frequencies are generally lower in some African ancestry cohorts. Because baseline allele frequencies fluctuate across distinct ancestries, the statistical power and clinical generalizability of findings can differ depending on an individual's genetic background, underscoring the importance of multi-ethnic genomic research.
Practical Implications and Clinical Perspective
Identifying an rs964188 genotype does not provide a clinical diagnosis of hypertriglyceridemia, dyslipidemia, or cardiovascular disease. Genetic testing results simply illustrate statistical predisposition within an intricate, multifactorial web of lipid biology. A person homozygous for the effect allele may maintain completely normal lipid values through a healthy lifestyle, whereas an individual lacking the effect allele might still develop severe hypertriglyceridemia due to diet, medication, or other genetic variants. Genotype data cannot replace a standard fasting lipid panel, which directly measures circulating lipids. Anyone concerned about their triglyceride levels or cardiovascular risk should review objective blood tests with a physician rather than attempting self-directed medical interventions or changing lipid-lowering therapies based on genetic markers.
How common is this variant?
The minor C allele frequency is approximately 10% to 15% among European populations, with frequencies reaching 25% to 30% or higher in East Asian cohorts and varying widely across other global ancestries.
Frequently asked questions
Does having the rs964188 risk allele mean I will develop high triglycerides?
No, carrying the risk allele does not mean you are guaranteed to develop hypertriglyceridemia. The variant confers a modest statistical shift in average lipid levels, but daily diet, physical activity, alcohol intake, and overall metabolic health remain the predominant drivers of clinical triglyceride concentrations.
Can I use my rs964188 genotype to adjust my cholesterol medications?
No, you should never start, stop, or change any medication based on an individual genetic variant. Medication decisions, including dosages for fibrates or statins, depend on direct blood test measurements and comprehensive clinical evaluations conducted by your doctor or pharmacist.
Why do different genetic testing companies report different letters for rs964188?
Genetic test results can differ because DNA consists of complementary paired strands. Depending on whether an assay reports the forward or reverse orientation, the alleles may be designated as C and G or their complementary counterparts, T and A.
Is rs964188 directly causing the change in lipid metabolism?
Because rs964188 is located in a non-coding region, it may not be the direct biochemical cause of the change. It is often inherited alongside other functional changes in the nearby APOA5 or APOC3 genes, serving as an informative genetic marker for the surrounding chromosomal region.
Sources & further reading
Educational information only, last refreshed 9/7/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs964188?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29